NR1H4 and lung disorder: In addition, the FXR for BAs has been shown to be expressed in human airway epithelial cells [57], and the agonists have been proven to have beneficial effects in a wide range of pulmonary diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis [58].